Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a groundbreaking…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
UC Davis Health Study Reveals Significant Choline Deficiencies in the Brains of Individuals with Anxiety Disorders
A groundbreaking meta-analysis led by researchers at UC Davis Health has identified a consistent chemical signature in the brains of…
Read More
Breakthrough in Van der Waals Semiconductors: XPANCEO and Nobel Laureate Unveil Light-Driven Optical Fabrication in Arsenic Trisulfide
Researchers at the XPANCEO Emerging Technologies Research Center, in a strategic collaboration with Nobel Laureate Professor Konstantin Novoselov of the…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access
The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…
Read More
Kyowa Kirin Secures FDA Approval for Enhanced Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia
Kyowa Kirin has announced a significant advancement in the treatment landscape for X-linked hypophosphatemia (XLH) in adult patients, following the…
Read More
Marshall University Researchers Uncover Gut Exosomes as Key Players in Age-Related Inflammation and Chronic Disease
Huntington, WV – Researchers at the Marshall University Joan C. Edwards School of Medicine have identified a critical link between…
Read More
TWiV 1286: Clinical update with Dr. Daniel Griffin
The latest episode of the podcast "This Week in Virology" (TWiV), number 1286, features Dr. Daniel Griffin and Vincent Racaniello…
Read More
Natural Selection Within the Testes Drives Increased Genetic Risk in Aging Fathers According to New Research
A groundbreaking pair of studies published in the journal Nature has fundamentally altered the scientific understanding of how genetic mutations…
Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
In a landmark move poised to reshape the landscape of pharmaceutical innovation, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven…
Read More
